Cargando…
Human Umbilical Cord Mesenchymal Stem Cells for Adjuvant Treatment of a Critically Ill COVID-19 Patient: A Case Report
BACKGROUND: COVID-19 (coronavirus disease 2019) has become a global public health emergency since patients were first detected in Wuhan, China, in December 2019. Currently, there are no satisfying antiviral medications and vaccines available. CASE PRESENTATION: We reported the treatment process and...
Autores principales: | Zhu, Yue, Zhu, Rongjia, Liu, Kun, Li, Xin, Chen, Dezhong, Bai, Dunyao, Luo, Jieli, Liu, Yixun, Zhang, Yan, Li, Li, Hu, Junfang, Xu, Dayong, Liu, Yan, Zhao, Robert Chunhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532065/ https://www.ncbi.nlm.nih.gov/pubmed/33061476 http://dx.doi.org/10.2147/IDR.S272645 |
Ejemplares similares
-
Human umbilical cord mesenchymal stem cell transplantation restores damaged ovaries
por: Zhu, Shao-Fang, et al.
Publicado: (2015) -
Acetylcholine secretion by motor neuron-like cells from umbilical cord mesenchymal stem cells
por: Liu, Xueyuan, et al.
Publicado: (2013) -
Umbilical cord mesenchymal stromal cells as critical COVID‐19 adjuvant therapy: A randomized controlled trial
por: Dilogo, Ismail Hadisoebroto, et al.
Publicado: (2021) -
Anti-oxidative effect of zinc in human umbilical cord mesenchymal stem cells
por: Lu, Xiaodan, et al.
Publicado: (2021) -
Urothelial Differentiation of Human Umbilical Cord-Derived Mesenchymal Stromal Cells In Vitro
por: Wu, Shuai, et al.
Publicado: (2013)